YOUR FREE GUIDES TO STAY UP TO DATE ON:
Quality & GMP Compliance
Common Pharma Artwork Hurdles
Brexit Pharma Artwork Challenges & Solutions
Optimising Your End-to-End Artwork ProcessWE CAN HELP
Perigord Resource Library
Welcome to our online resources library. Perigord promote a culture of quality, operational excellence and GMP compliant processes. These documents share some of our experience in managing artwork through the artwork lifecycle process, and what we believe is critical in ensuring excellence. We hope you will find these resources helpful.
Perigord explains the importance of compliant, validated labelling and artwork solutions in the pharmaceutical sector.
If you are looking for fully compliant and error-free pharma artworks to hit the market efficiently while reducing your stress levels, keep an eye on the following four most common pharma artwork hurdles.
We've been looking at some of the possible outcomes of Brexit for the Life Science Industry and specifically, what effect it could have on artwork. Our regulatory experts have put together this overview of the challenges and solutions to the Brexit conundrum.
Perigord strives to be a responsible corporate citizen, wherever we do business.
Fundamentals. The drab cousins of the headline grabbers like AI or Pharma 4.0. But focussing on them can be the investment that offers the most long-term rewards for companies in terms of risk mitigation, cost reduction and improved overall agility.
Launching your Rx product into the US market can be a lot like trying to land a fighter jet on the pitching deck of an aircraft carrier in the middle of a raging storm.
As serialization codes have to be included on all salable units, this chapter focuses on label design and serialization elements that are needed to comply with the new regulations.
The GLAMS Business Intelligence and enhanced KPI Reporting feature provides configurable dashboards allowing faster analysis and reporting.
According to recent research, the global pharmaceutical packaging market is forecasted to reach more than US$80 billion in revenue by 2020.
Lenny Figorski talks about the development phases leading to FDA submission, as well as activities related to validation and verification prior to product launch.
Perigord explains the importance of compliant, validated labelling and artwork solutions in the pharmaceutical sector and is offering the solutions to optimise your end-to-end artwork process.
Risk in the Life Sciences industry is inevitable. It’s not a matter of if your company is going to manage it, it’s a matter of how, and more importantly, how well.
Centralised Global QMS Certified to ISO 9001:2015 & PS 9000:2016